RMFCX
Price
$61.18
Change
-$0.20 (-0.33%)
Updated
Sep 12 closing price
Net Assets
110.3B
SVFCX
Price
$79.51
Change
-$1.01 (-1.25%)
Updated
Sep 12 closing price
Net Assets
4.6B
Interact to see
Advertisement

RMFCX vs SVFCX

Header iconRMFCX vs SVFCX Comparison
Open Charts RMFCX vs SVFCXBanner chart's image
American Funds American Mutual R3
Price$61.18
Change-$0.20 (-0.33%)
VolumeN/A
Net Assets110.3B
Smead Value C
Price$79.51
Change-$1.01 (-1.25%)
VolumeN/A
Net Assets4.6B
RMFCX vs SVFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RMFCX vs. SVFCX commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and SVFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 110B vs. SVFCX (4.6B). RMFCX pays higher dividends than SVFCX: RMFCX (1.24) vs SVFCX (0.60). RMFCX was incepted earlier than SVFCX: RMFCX (23 years) vs SVFCX (5 years). SVFCX (1.80) is less costly to investors than RMFCX (0.91). RMFCX is a more actively managed with annual turnover of: 31.00 vs. SVFCX (13.30). RMFCX has a lower initial minimum investment than SVFCX: RMFCX (250) vs SVFCX (25000). RMFCX annual gain was more profitable for investors over the last year : 7.96 vs. SVFCX (1.04). SVFCX return over 5 years is better than : 82.44 vs. RMFCX (60.22).
RMFCXSVFCXRMFCX / SVFCX
Total Expense Ratio0.911.8051%
Annual Report Gross Expense Ratio0.911.8051%
Fund Existence23 years5 years-
Gain YTD12.7674.084313%
Front LoadN/AN/A-
Min. Initial Investment250250001%
Min. Initial Investment IRAN/AN/A-
Net Assets110B4.6B2,391%
Annual Yield % from dividends1.240.60204%
Returns for 1 year7.961.04767%
Returns for 3 years32.8732.33102%
Returns for 5 years60.2282.4473%
Returns for 10 years93.48N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRTA4.300.09
+2.14%
Strata Critical Medical Inc
ABLLL25.100.05
+0.20%
Abacus Global Management Inc. 9.875% Fixed Rate Senior Notes due 2028
TILE28.52-0.12
-0.42%
Interface
CUE0.74-0.02
-3.16%
Cue Biopharma
GAP22.90-1.33
-5.49%
Gap Inc (The)